The Tema Cardiovascular and Metabolic ETF (HRTS) tracks companies involved in the treatment of cardio-metabolic diseases — a term that links cardiovascular diseases, obesity and diabetes.
Replacing a 700-year-old system of recording asset ownership with digital chips comes with its own set of risks.
The SEC also charged the firm with failing to adhere to policies and procedures designed to catch evidence of excessive trading in client accounts.
Rothschild, a former Morningstar and Apex executive, joins the global PE firm as an operating partner to help identify opportunities in the wealthtech space.